<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05094089</url>
  </required_header>
  <id_info>
    <org_study_id>SYN 20-01</org_study_id>
    <nct_id>NCT05094089</nct_id>
  </id_info>
  <brief_title>Assessment of GORE® SYNECOR Biomaterial in Focused Patient Populations and Long-Term Application</brief_title>
  <acronym>SYN 20-01</acronym>
  <official_title>Assessment of GORE® SYNECOR Biomaterial in Focused Patient Populations and Long-Term Application</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>W.L.Gore &amp; Associates</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>W.L.Gore &amp; Associates</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The SYN 20-01 Study is a non-interventional, prospective, multicenter, multicohort,&#xD;
      international, post-market clinical investigation looking into the assessment of GORE®&#xD;
      SYNECOR Biomaterial in focused patient populations and in long-term application.&#xD;
&#xD;
      Patients with ventral / incisional hernia amenable to hernia mesh repair will be enrolled&#xD;
      into two cohorts (US and EU cohort) and followed-up over the period of 60 months.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">April 30, 2022</start_date>
  <completion_date type="Anticipated">October 31, 2028</completion_date>
  <primary_completion_date type="Anticipated">October 31, 2025</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Hernia Recurrence</measure>
    <time_frame>24 Months</time_frame>
    <description>Hernia Recurrence Treated Location</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Hernia Recurrence</measure>
    <time_frame>60 Months</time_frame>
    <description>Hernia Recurrence Treated Location</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Hospital Re-Admission</measure>
    <time_frame>60 Months</time_frame>
    <description>Device or procedural-related</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Thirty-Day Mortality</measure>
    <time_frame>30 Day</time_frame>
    <description>Mortality of all causes</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>SSO within 24 months post-procedure</measure>
    <time_frame>24 Months</time_frame>
    <description>Surgical Site Occurrence (SSO)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>SSI (Surgical Site Infection)</measure>
    <time_frame>60 Months</time_frame>
    <description>Surgical Site Infection (SSI)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Freedom from mesh-involved events</measure>
    <time_frame>60 Months</time_frame>
    <description>Freedom from mesh-involved events</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Major Seroma (clinically confirmed)</measure>
    <time_frame>60 Months</time_frame>
    <description>Major Seroma as clinically assessed (physiological parameters) and defined as seroma requiring treatment in the presence of infection, recurrence, mesh rejection or the need to be punctured/aspirated will be described without specific hypothesis or formal goal. Number of subjects with reported major seroma will be described as clinically confirmed by the investigator.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Quality of Life (QoL) - SF 36 Questionnaire</measure>
    <time_frame>60 Months</time_frame>
    <description>SF 36 Questionnaire (36-Item Short Form Survey Instrument; possible score ranges from 0 to 100 points. 0 points represent the greatest possible limitation of health, while 100 points represent the absence of health restrictions)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Quality of Life (QoL) - Carolinas Comfort Scale (CCS)</measure>
    <time_frame>60 Months</time_frame>
    <description>Carolinas Comfort Scale (CCS); CCS was designed that a lower score indicates a favorable health status; the total score is based on a scale of 0 - 115)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ventral Hernia Recurrence Inventory sensitivity / specificity within 60 Month Follow-Up</measure>
    <time_frame>60 Months</time_frame>
    <description>VHRI Survey (Ventral Hernia Recurrence Inventory)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse Events by Clavien Dindo Classification</measure>
    <time_frame>60 Months</time_frame>
    <description>Adverse Events by Clavien Dindo Classification</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Surgical Site Occurrences (SSOPI) requiring Procedural Intervention</measure>
    <time_frame>24 Months</time_frame>
    <description>Surgical Site Occurrences (SSOPI) requiring Procedural Intervention</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Surgical Site Occurrences (SSOPI) requiring Procedural Intervention</measure>
    <time_frame>60 Months</time_frame>
    <description>Surgical Site Occurrences (SSOPI) requiring Procedural Intervention</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">320</enrollment>
  <condition>Hernia, Ventral</condition>
  <condition>Hernia Incisional</condition>
  <condition>Hernia Incisional Ventral</condition>
  <arm_group>
    <arm_group_label>SYNECOR IP Device</arm_group_label>
    <description>Hernia mesh repair with GORE® SYNECOR Intraperitoneal Biomaterial</description>
  </arm_group>
  <arm_group>
    <arm_group_label>SYNECOR PRE Device</arm_group_label>
    <description>Hernia mesh repair with GORE® SYNECOR Preperitoneal Biomaterial</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Hernia repair with mesh</intervention_name>
    <description>Hernia repair with GORE® SYNECOR Biomaterial; technical approach laparoscopic, robotic or open surgical / minimally invasive surgery</description>
    <arm_group_label>SYNECOR IP Device</arm_group_label>
    <arm_group_label>SYNECOR PRE Device</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        The SYN 20-01 study population will consist of patients who present with ventral/incisional&#xD;
        hernia disease requiring treatment per the evaluating physician. Eligible study subjects&#xD;
        need to be amenable to treatment with a permanent synthetic mesh as suggested by the&#xD;
        inclusion and exclusion criteria for each study cohort.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Key Inclusion Criteria - IP Cohort:&#xD;
&#xD;
          -  De-Novo ventral/incisional hernia amenable to repair with GORE® SYNECOR IP Biomaterial&#xD;
&#xD;
          -  Clean wound (CDC Wound Class I)&#xD;
&#xD;
          -  mVHWG Grade 1 or 2 (modified Ventral Hernia Working Group)&#xD;
&#xD;
        Key Exclusion Criteria - IP Cohort:&#xD;
&#xD;
        - Wound is either clean-contaminated, contaminated or dirty-infected&#xD;
&#xD;
        Key Inclusion Criteria - PRE Cohort:&#xD;
&#xD;
          -  De-novo ventral/incisional hernia, with subject anatomy and surgical plan is amenable&#xD;
             to open surgical repair or minimally invasive surgery with the GORE® SYNECOR PRE&#xD;
             Biomaterial placed in a sublay fashion within the preperitoneal space&#xD;
&#xD;
          -  Clean wound (CDC Wound Class I)&#xD;
&#xD;
          -  mVHWG Grade 1 or 2 (modified Ventral Hernia Working Group)&#xD;
&#xD;
        Key Exclusion Criteria - PRE Cohort:&#xD;
&#xD;
        - Wound is either clean-contaminated, contaminated or dirty-infected&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Petra Kremer</last_name>
    <phone>+49162 2435554</phone>
    <email>pkremer@wlgore.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>James Williams</last_name>
    <phone>+16232345490</phone>
    <email>jamwilli@wlgore.com</email>
  </overall_contact_backup>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>October 5, 2021</study_first_submitted>
  <study_first_submitted_qc>October 22, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">October 26, 2021</study_first_posted>
  <last_update_submitted>October 22, 2021</last_update_submitted>
  <last_update_submitted_qc>October 22, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 26, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Hernia Repair</keyword>
  <keyword>Hernia Mesh Treatment</keyword>
  <keyword>Ventral Hernia</keyword>
  <keyword>Incisional Hernia</keyword>
  <keyword>Intraperitoneal</keyword>
  <keyword>Preperitoneal</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hernia</mesh_term>
    <mesh_term>Hernia, Ventral</mesh_term>
    <mesh_term>Incisional Hernia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

